share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Watanabe Todd Franklin

SEC announcement ·  Feb 15 18:33
Summary by Moomoo AI
Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, Inc. [ARQT], reported multiple acquisitions of common stock on February 13, 2024. The transactions, described as grants, awards, or other acquisitions, resulted in a total direct acquisition of 216,882 shares. Following these transactions, Watanabe's direct holdings in the company amounted to 891,901 shares. Additionally, indirect holdings through trusts and an LLC totaled 231,140 shares, with the largest single indirect holding being 124,956 shares by a trust.
Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, Inc. [ARQT], reported multiple acquisitions of common stock on February 13, 2024. The transactions, described as grants, awards, or other acquisitions, resulted in a total direct acquisition of 216,882 shares. Following these transactions, Watanabe's direct holdings in the company amounted to 891,901 shares. Additionally, indirect holdings through trusts and an LLC totaled 231,140 shares, with the largest single indirect holding being 124,956 shares by a trust.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more